| Company Name | Fiscal Year | EPS (Estimated) | Revenue (Estimated) | Exchange | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Nov 30, 2026 |
|||||||||
| Q4 FY26 | $0.83 | $1.31B |
NASDAQ |
||||||
|
Anavex Life Sciences
AVXL
|
Q2 FY26 | -$0.11 | - |
NASDAQ |
|||||
Showing
1
to
2
of
2 entries